Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.

Canu L, Van Hemert JAW, Kerstens MN, Hartman RP, Khanna A, Kraljevic I, Kastelan D, Badiu C, Ambroziak U, Tabarin A, Haissaguerre M, Buitenwerf E, Visser A, Mannelli M, Arlt W, Chortis V, Bourdeau I, Gagnon N, Buchy M, Borson-Chazot F, Deutschbein T, Fassnacht M, Hubalewska-Dydejczyk A, Motyka M, Rzepka E, Casey RT, Challis BG, Quinkler M, Vroonen L, Spyroglou A, Beuschlein F, Lamas C, Young WF, Bancos I, Timmers HJLM.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):312-318. doi: 10.1210/jc.2018-01532.

PMID:
30383267
2.

Mouse Models of Primary Aldosteronism: From Physiology to Pathophysiology.

Aragao-Santiago L, Gomez-Sanchez CE, Mulatero P, Spyroglou A, Reincke M, Williams TA.

Endocrinology. 2017 Dec 1;158(12):4129-4138. doi: 10.1210/en.2017-00637.

3.

Changes in Body Mass Index in Pheochromocytoma Patients Following Adrenalectomy.

Spyroglou A, Adolf C, Hahner S, Quinkler M, Ladurner R, Reincke M, Beuschlein F.

Horm Metab Res. 2017 Mar;49(3):208-213. doi: 10.1055/s-0042-124189. Epub 2017 Feb 21.

PMID:
28222463
4.

Genetic characterization of a mouse line with primary aldosteronism.

Perez-Rivas LG, Rhayem Y, Sabrautzki S, Hantel C, Rathkolb B, Hrabě de Angelis M, Reincke M, Beuschlein F, Spyroglou A.

J Mol Endocrinol. 2017 Feb;58(2):67-78. doi: 10.1530/JME-16-0200. Epub 2016 Dec 13.

PMID:
27965370
5.

Adrenal and Ovarian Phenotype of a Tissue-Specific Urocortin 2-Overexpressing Mouse Model.

Spyroglou A, Riester A, Mueller-Peltzer K, Lu A, Rohde J, Hantel C, Kuehne C, Kulle A, Riepe F, Deussing JM, Beuschlein F.

Endocrinology. 2015 Jul;156(7):2646-56. doi: 10.1210/en.2014-1971. Epub 2015 May 5.

PMID:
25942073
6.

Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion.

Spyroglou A, Bozoglu T, Rawal R, De Leonardis F, Sterner C, Boulkroun S, Benecke AG, Monti L, Zennaro MC, Petersen AK, Döring A, Rossi A, Bidlingmaier M, Warth R, Gieger C, Reincke M, Beuschlein F.

Hypertension. 2014 May;63(5):1102-9. doi: 10.1161/HYPERTENSIONAHA.113.02504. Epub 2014 Mar 3.

PMID:
24591336
7.

Gender-, strain-, and inheritance-dependent variation in aldosterone secretion in mice.

Spyroglou A, Sabrautzki S, Rathkolb B, Bozoglu T, Hrabé de Angelis M, Reincke M, Bidlingmaier M, Beuschlein F.

J Endocrinol. 2012 Dec;215(3):375-81. doi: 10.1530/JOE-12-0429. Epub 2012 Sep 26.

PMID:
23015642
8.

Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies.

Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, Völzke H, Beuschlein F, Seissler J, Rettig R, Felix SB, Biffar R, Döring A, Meisinger C, Peters A, Wichmann HE, Nauck M, Wallaschofski H, Reincke M.

Eur J Endocrinol. 2012 Jul;167(1):7-15. doi: 10.1530/EJE-11-1013. Epub 2012 Apr 10.

PMID:
22495491
9.

Urocortin-dependent effects on adrenal morphology, growth, and expression of steroidogenic enzymes in vivo.

Riester A, Spyroglou A, Neufeld-Cohen A, Chen A, Beuschlein F.

J Mol Endocrinol. 2012 Feb 27;48(2):159-67. doi: 10.1530/JME-11-0144. Print 2012 Apr.

PMID:
22312132
10.

ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland.

Riester A, Issler O, Spyroglou A, Rodrig SH, Chen A, Beuschlein F.

Endocrinology. 2012 Jan;153(1):212-22. doi: 10.1210/en.2011-1285. Epub 2011 Nov 29.

PMID:
22128032
11.

Primary adrenal lymphoma: 3 case reports with different outcomes.

Spyroglou A, Schneider HJ, Mussack T, Reincke M, von Werder K, Beuschlein F.

Exp Clin Endocrinol Diabetes. 2011 Apr;119(4):208-13. doi: 10.1055/s-0031-1271629. Epub 2011 Mar 3. Review.

PMID:
21374545
12.

A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.

Kaplan RC, Petersen AK, Chen MH, Teumer A, Glazer NL, Döring A, Lam CS, Friedrich N, Newman A, Müller M, Yang Q, Homuth G, Cappola A, Klopp N, Smith H, Ernst F, Psaty BM, Wichmann HE, Sawyer DB, Biffar R, Rotter JI, Gieger C, Sullivan LS, Völzke H, Rice K, Spyroglou A, Kroemer HK, Ida Chen YD, Manolopoulou J, Nauck M, Strickler HD, Goodarzi MO, Reincke M, Pollak MN, Bidlingmaier M, Vasan RS, Wallaschofski H.

Hum Mol Genet. 2011 Mar 15;20(6):1241-51. doi: 10.1093/hmg/ddq560. Epub 2011 Jan 7.

13.

Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism.

Spyroglou A, Wagner S, Gomez-Sanchez C, Rathkolb B, Wolf E, Manolopoulou J, Reincke M, Bidlingmaier M, Hrabé de Angelis M, Beuschlein F.

Endocrinology. 2011 Jan;152(1):326-31. doi: 10.1210/en.2010-1081. Epub 2010 Nov 10.

PMID:
21068155
14.

A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma.

Sun M, Manolopoulou J, Spyroglou A, Beuschlein F, Hantel C, Wu Z, Bielohuby M, Hoeflich A, Liu C, Bidlingmaier M.

Steroids. 2010 Dec 12;75(13-14):1089-96. doi: 10.1016/j.steroids.2010.07.005. Epub 2010 Jul 21.

PMID:
20654638
15.

Identification of adrenal genes regulated in a potassium-dependent manner.

Dierks A, Lichtenauer UD, Sackmann S, Spyroglou A, Shapiro I, Geyer M, Manonopoulou J, Reincke M, Hantel C, Beuschlein F.

J Mol Endocrinol. 2010 Oct;45(4):193-206. doi: 10.1677/JME-09-0171. Epub 2010 Jul 20.

PMID:
20647392
16.

Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits.

Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A.

Mol Psychiatry. 2010 Apr;15(4):426-41, 339. doi: 10.1038/mp.2009.115. Epub 2009 Nov 3. Erratum in: Mol Psychiatry. 2010 Apr;15(4):442.

PMID:
19884890
17.

Saliva as a medium for aldosterone measurement in repeated sampling studies.

Manolopoulou J, Mulatero P, Maser-Gluth C, Rossignol P, Spyroglou A, Vakrilova Y, Petersenn S, Zwermann O, Plouin PF, Reincke M, Bidlingmaier M.

Steroids. 2009 Oct;74(10-11):853-8. doi: 10.1016/j.steroids.2009.05.006. Epub 2009 May 27.

PMID:
19481102
18.

Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice.

Spyroglou A, Manolopoulou J, Wagner S, Bidlingmaier M, Reincke M, Beuschlein F.

J Mol Endocrinol. 2009 May;42(5):407-13. doi: 10.1677/JME-08-0167. Epub 2009 Feb 12.

PMID:
19221003

Supplemental Content

Loading ...
Support Center